All Stories

  1. Enhancing Cytosolic Internalization of [177Lu]Lu–iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule

    Article • International Journal of Molecular Sciences, December 2025, MDPI AG

    Blanca Ocampo-Garcia

  2. Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview

    Article • Pharmaceutics, October 2025, MDPI AG

    Blanca Ocampo-Garcia

  3. Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose

    Article • International Journal of Molecular Sciences, July 2025, MDPI AG

    Blanca Ocampo-Garcia

  4. Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1

    Article • Pharmaceutics, July 2025, MDPI AG

    Blanca Ocampo-Garcia

  5. Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study

    Article • Pharmaceutics, October 2024, MDPI AG

    Blanca Ocampo-Garcia

  6. 68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases

    Article • Pharmaceutics, April 2024, MDPI AG

    Blanca Ocampo-Garcia

  7. Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications

    Article • Nanomaterials, January 2024, MDPI AG

    Blanca Ocampo-Garcia

  8. Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Blanca Ocampo-Garcia

  9. 99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe

    Article • Pharmaceutics, November 2023, MDPI AG

    Blanca Ocampo-Garcia

  10. 225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    Blanca Ocampo-Garcia

  11. Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Blanca Ocampo-Garcia

  12. Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses

    Article • Pharmaceutics, July 2023, MDPI AG

    Blanca Ocampo-Garcia

  13. Toxicity Assessment of [177Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes

    Article • Nanomaterials, November 2022, MDPI AG

    Blanca Ocampo-Garcia

  14. Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications

    Article • Molecules, October 2022, MDPI AG

    Blanca Ocampo-Garcia

  15. 131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry

    Article • Molecules, August 2022, MDPI AG

    Blanca Ocampo-Garcia

  16. [99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities

    Article • Pharmaceuticals, June 2022, MDPI AG

    Blanca Ocampo-Garcia

  17. Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer

    Article • Pharmaceutics, May 2022, MDPI AG

    Blanca Ocampo-Garcia

  18. IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery

    Article • Pharmaceutics, May 2022, MDPI AG

    Blanca Ocampo-Garcia

  19. [99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients

    Article • Pharmaceuticals, May 2022, MDPI AG

    Blanca Ocampo-Garcia

  20. 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins

    Article • Molecules, March 2022, MDPI AG

    Blanca Ocampo-Garcia

  21. Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image

    Article • Pharmaceutics, March 2022, MDPI AG

    Blanca Ocampo-Garcia

  22. Targeted photodynamic therapy using reconstituted high-density lipoproteins as rhodamine transporters

    Article • Photodiagnosis and Photodynamic Therapy, March 2022, Elsevier

    Blanca Ocampo-Garcia

  23. Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging

    Article • Molecules, January 2022, MDPI AG

    Blanca Ocampo-Garcia

  24. Preparation and Dosimetry Assessment of 166Dy2O3/166Ho2O3-iPSMA Nanoparticles for Targeted Hepatocarcinoma Radiotherapy

    Article • Journal of Nanoscience and Nanotechnology, November 2021, American Scientific Publishers

    Blanca Ocampo-Garcia

  25. A Multimodal Theranostic System Prepared from High-Density Lipoprotein Carrier of Doxorubicin and 177Lu

    Article • Journal of Biomedical Nanotechnology, November 2021, American Scientific Publishers

    Blanca Ocampo-Garcia

  26. Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications

    Article • Pharmaceutics, July 2021, MDPI AG

    Blanca Ocampo-Garcia

  27. Preclinical dosimetric studies of 177Lu‐scFvD2B and comparison with 177Lu‐PSMA‐617 and 177Lu‐iPSMA endoradiotherapeutic agents

    Article • Medical Physics, June 2021, Wiley

    Blanca Ocampo-Garcia

  28. [68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging

    Article • Nuclear Medicine and Biology, May 2021, Elsevier

    Blanca Ocampo-Garcia

  29. Electron transfer reactions in rhodamine: Potential use in photodynamic therapy

    Article • Journal of Photochemistry and Photobiology A Chemistry, March 2021, Elsevier

    Blanca Ocampo-Garcia

  30. Development of 177Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer

    Article • Journal of Biomedical Nanotechnology, February 2021, American Scientific Publishers

    Blanca Ocampo-Garcia

  31. Drug Delivery Systems‐Based Dendrimers and Polymer Micelles for Nuclear Diagnosis and Therapy

    Article • Macromolecular Bioscience, January 2021, Wiley

    Blanca Ocampo-Garcia

  32. Radiolabeled Protein-inhibitor Peptides with Rapid Clinical Translation towards Imaging and Therapy

    Article • Current Medicinal Chemistry, December 2020, Bentham Science Publishers

    Dr Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-Garcia

  33. Synthesis, chemical and biochemical characterization of Lu2O3-iPSMA nanoparticles activated by neutron irradiation

    Article • Materials Science and Engineering C, December 2020, Elsevier

    Blanca Ocampo-Garcia

  34. Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen

    Article • Scientific Reports, June 2020, Springer Science + Business Media

    Phd Giulio Fracasso, Blanca Ocampo-Garcia

  35. Hybrid (2D/3D) Dosimetry of Radiolabeled Gold Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer

    Article • Contrast Media & Molecular Imaging, May 2020, Wiley

    Blanca Ocampo-Garcia

  36. Synthesis and Biochemical Evaluation of Samarium-153 Oxide Nanoparticles Functionalized with iPSMA-Bombesin Heterodimeric Peptide

    Article • Journal of Biomedical Nanotechnology, May 2020, American Scientific Publishers

    Blanca Ocampo-Garcia

  37. 99mTc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans

    Article • Contrast Media & Molecular Imaging, April 2020, Wiley

    Blanca Ocampo-Garcia

  38. Synthesis and preclinical evaluation of the 99mTc-/177Lu-CXCR4-L theranostic pair for in vivo chemokine-4 receptor-specific targeting

    Article • Journal of Radioanalytical and Nuclear Chemistry, February 2020, Springer Science + Business Media

    Blanca Ocampo-Garcia

  39. 177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer

    Article • Materials Science and Engineering C, December 2019, Elsevier

    Blanca Ocampo-Garcia

  40. Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis

    Article • Materials Science and Engineering C, October 2019, Elsevier

    Blanca Ocampo-Garcia

  41. Synthesis and Evaluation of 177Lu-DOTA-DN(PTX)-BN for Selective and Concomitant Radio and Drug—Therapeutic Effect on Breast Cancer Cells

    Article • Polymers, September 2019, MDPI AG

    Blanca Ocampo-Garcia

  42. Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer

    Article • Nuclear Medicine Communications, March 2019, Wolters Kluwer Health

    Blanca Ocampo-Garcia

  43. [99mTc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging

    Article • Nanoscale, January 2019, Royal Society of Chemistry

    Dr Sangram Raut, Blanca Ocampo-Garcia

  44. 177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

    Article • Contrast Media & Molecular Imaging, November 2018, Hindawi Publishing Corporation

    GUILLERMINA FERRO-FLORES, Erika Azorín-Vega, Blanca Ocampo-Garcia

  45. Dual-Targeted Therapy and Molecular Imaging with Radiolabeled Nanoparticles

    Article • November 2018, Springer Science + Business Media

    Blanca Ocampo-Garcia

  46. Preparation and preclinical evaluation of 68Ga-iPSMA-BN as a potential heterodimeric radiotracer for PET-imaging of prostate cancer

    Article • Journal of Radioanalytical and Nuclear Chemistry, October 2018, Springer Science + Business Media

    Blanca Ocampo-Garcia

  47. In vitro and in vivo synergistic effect of radiotherapy and plasmonic photothermal therapy on the viability of cancer cells using 177Lu–Au-NLS-RGD-Aptamer nanoparticles under laser irradiation

    Article • Journal of Radioanalytical and Nuclear Chemistry, October 2018, Springer Science + Business Media

    Blanca Ocampo-Garcia

  48. 177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: synthesis and assessment of the ability to target the prostate specific membrane antigen

    Article • Journal of Radioanalytical and Nuclear Chemistry, October 2018, Springer Science + Business Media

    Blanca Ocampo-Garcia

  49. Correction to: Preclinical Biokinetic Modelling of Tc-99m Radiophamaceuticals Obtained from Semi-Automatic Image Processing

    Article • Journal of Medical and Biological Engineering, February 2018, Springer Science + Business Media

    Blanca Ocampo-Garcia

  50. 99mTc-exendin(9-39)/octreotide

    Article • Nuclear Medicine Communications, November 2017, Wolters Kluwer Health

    Blanca Ocampo-Garcia

  51. Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical

    Article • Journal of Radioanalytical and Nuclear Chemistry, October 2017, Springer Science + Business Media

    Blanca Ocampo-Garcia

  52. PMM nanoparticles grafted with RGD to detect neovasculature in tumoral process

    Article • Current Pharmaceutical Design, September 2017, Bentham Science Publishers

    Blanca Ocampo-Garcia, GUILLERMINA FERRO-FLORES

  53. Synthesis and in vitro evaluation of an antiangiogenic cancer-specific dual-targeting 177Lu-Au-nanoradiopharmaceutical

    Article • Journal of Radioanalytical and Nuclear Chemistry, September 2017, Springer Science + Business Media

    Blanca Ocampo-Garcia

  54. 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients

    Article • Nuclear Medicine and Biology, September 2017, Elsevier

    Blanca Ocampo-Garcia

  55. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin

    Article • Materials Science and Engineering C, July 2017, Elsevier

    Blanca Ocampo-Garcia

  56. Preclinical Biokinetic Modelling of Tc-99m Radiophamaceuticals Obtained from Semi-Automatic Image Processing

    Article • Journal of Medical and Biological Engineering, June 2017, Springer Science + Business Media

    Blanca Ocampo-Garcia

  57. Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT

    Article • Nuclear Medicine and Biology, May 2017, Elsevier

    Blanca Ocampo-Garcia

  58. Physicochemical behaviour of a dinuclear uranyl complex formed with an octaphosphinoylated para - tert -butylcalix[8]arene. Spectroscopic studies in solution and in the solid state

    Article • Polyhedron, February 2017, Elsevier

    Blanca Ocampo-Garcia

  59. Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells

    Article • Molecular Imaging, January 2017, SAGE Publications

    Dr Guillermina Ferro-Flores, GUILLERMINA FERRO-FLORES, Blanca Ocampo-Garcia

  60. Preparation and Characterization of a Tumor-Targeting Dual-Image System Based on Iron Oxide Nanoparticles Functionalized with Folic Acid and Rhodamine

    Article • Journal of Nanomaterials, January 2017, Hindawi Publishing Corporation

    Blanca Ocampo-Garcia

  61. Antibacterial Efficacy of Gold and Silver Nanoparticles Functionalized with the Ubiquicidin (29–41) Antimicrobial Peptide

    Article • Journal of Nanomaterials, January 2017, Hindawi Publishing Corporation

    Blanca Ocampo-Garcia, GUILLERMINA FERRO-FLORES

  62. Hydrogels based on poly(ethylene glycol) as scaffolds for tissue engineering application: biocompatibility assessment and effect of the sterilization process

    Article • Journal of Materials Science Materials in Medicine, October 2016, Springer Science + Business Media

    Blanca Ocampo-Garcia

  63. Improved radiopharmaceutical based on 99mTc-Bombesin–folate for breast tumour imaging

    Article • Nuclear Medicine Communications, April 2016, Wolters Kluwer Health

    Blanca Ocampo-Garcia

  64. Synthesis and evaluation of Lys1(α,γ-Folate)Lys3(177Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer

    Article • Applied Radiation and Isotopes, January 2016, Elsevier

    Blanca Ocampo-Garcia

  65. 177Lu-Dendrimer Conjugated to Folate and Bombesin with Gold Nanoparticles in the Dendritic Cavity: A Potential Theranostic Radiopharmaceutical

    Article • Journal of Nanomaterials, January 2016, Hindawi Publishing Corporation

    Blanca Ocampo-Garcia

  66. A freeze-dried kit formulation for the preparation of Lys27(99mTc-EDDA/HYNIC)-Exendin(9-39)/99mTc-EDDA/HYNIC-Tyr3-Octreotide to detect benign and malignant insulinomas

    Article • Nuclear Medicine and Biology, December 2015, Elsevier

    Blanca Ocampo-Garcia

  67. Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability

    Article • Journal of Nanoscience and Nanotechnology, December 2015, American Scientific Publishers

    Blanca Ocampo-Garcia

  68. Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging

    Article • Journal of Nanoscience and Nanotechnology, June 2015, American Scientific Publishers

    Blanca Ocampo-Garcia

  69. Tumoral fibrosis effect on the radiation absorbed dose of 177Lu–Tyr3-octreotate and 177Lu–Tyr3-octreotate conjugated to gold nanoparticles

    Article • Applied Radiation and Isotopes, June 2015, Elsevier

    Blanca Ocampo-Garcia

  70. Preparation of Heterobivalent and Multivalent Radiopharmaceuticals to Target Tumors Over-Expressing Integrins

    Article • January 2015, Springer Science + Business Media

    Blanca Ocampo-Garcia

  71. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging

    Article • Nuclear Medicine Communications, April 2014, Wolters Kluwer Health

    Blanca Ocampo-Garcia

  72. Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to 177Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice

    Article • Journal of Biomedical Nanotechnology, March 2014, American Scientific Publishers

    Blanca Ocampo-Garcia

  73. Multifunctional Radiolabeled Nanoparticles for Targeted Therapy

    Article • Current Medicinal Chemistry, November 2013, Bentham Science Publishers

    Blanca Ocampo-Garcia

  74. Multifunctional targeted therapy system based on99mTc/177Lu-labeled gold nanoparticles-Tat(49-57)-Lys3-bombesin internalized in nuclei of prostate cancer cells

    Article • Journal of Labelled Compounds, July 2013, Wiley

    Blanca Ocampo-Garcia

  75. Design and biological evaluation of 99mTc-N2S2-Tat(49–57)-c(RGDyK): A hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins

    Article • Nuclear Medicine and Biology, May 2013, Elsevier

    Professor Luis M De Leon Rodriguez, Blanca Ocampo-Garcia

  76. Laser Heating of Gold Nanospheres Functionalized with Octreotide:In VitroEffect on HeLa Cell Viability

    Article • Photomedicine and Laser Surgery, January 2013, Mary Ann Liebert Inc

    Blanca Ocampo-Garcia

  77. Engineered Multifunctional RGD-Gold Nanoparticles for the Detection of Tumour-Specific α(ν)β(3) Expression: Chemical Characterisation and Ecotoxicological Risk Assessment

    Article • Journal of Biomedical Nanotechnology, December 2012, American Scientific Publishers

    Blanca Ocampo-Garcia

  78. 177Lu‐labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing α(ν)β(3) integrins

    Article • Journal of Labelled Compounds and Radiopharmaceuticals, March 2012, Wiley

    Professor Luis M De Leon Rodriguez, Blanca Ocampo-Garcia

  79. Multifunctional Targeted Radiotherapy System for Induced Tumours Expressing Gastrin-releasing Peptide Receptors

    Article • Current Nanoscience, March 2012, Bentham Science Publishers

    Blanca Ocampo-Garcia

  80. Development of Specific Radiopharmaceuticals for Infection Imaging by Targeting Infectious Micro-organisms

    Article • Current Pharmaceutical Design, March 2012, Bentham Science Publishers

    Blanca Ocampo-Garcia

  81. Cyclization of RGD peptide sequences via the macrocyclic chelator DOTA for integrin imaging

    Article • Dalton Transactions, January 2012, Royal Society of Chemistry

    Professor Luis M De Leon Rodriguez, Blanca Ocampo-Garcia

  82. Kit for preparation of multimeric receptor-specific 99mTc-radiopharmaceuticals based on gold nanoparticles

    Article • Nuclear Medicine Communications, November 2011, Wolters Kluwer Health

    Blanca Ocampo-Garcia

  83. Multimeric System of99mTc-Labeled Gold Nanoparticles Conjugated to c[RGDfK(C)] for Molecular Imaging of Tumor α(v)β(3) Expression

    Article • Bioconjugate Chemistry, May 2011, American Chemical Society (ACS)

    Blanca Ocampo-Garcia

  84. 99mTc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection

    Article • Nuclear Medicine and Biology, January 2011, Elsevier

    Professor Luis M De Leon Rodriguez, Blanca Ocampo-Garcia

  85. Click chemistry for [99mTc(CO)3] labeling of Lys3-bombesin

    Article • Applied Radiation and Isotopes, December 2010, Elsevier

    Blanca Ocampo-Garcia

  86. Lys3-Bombesin Conjugated to99mTc-Labelled Gold Nanoparticles for In Vivo Gastrin Releasing Peptide-Receptor Imaging

    Article • Journal of Biomedical Nanotechnology, August 2010, American Scientific Publishers

    Professor Luis M De Leon Rodriguez, Blanca Ocampo-Garcia

  87. Biokinetics of [sup 99m]Tc-labeled gold nanoparticles conjugated to mannose for specific sentinel node detection

    Article • January 2010, American Institute of Physics

    Blanca Ocampo-Garcia

  88. Gold nanoparticles conjugated to [Tyr3]Octreotide peptide

    Article • Biophysical Chemistry, December 2008, Elsevier

    Blanca Ocampo-Garcia